
Bicara Therapeutics Inc.
Bicara Therapeutics Inc. (BCAX)
WebsitePrice
Market cap
Next catalystJan 2027ficerafusp alfa — mCRC monotherapy and pembrolizumab-combination expansion cohorts · Phase 1 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
BCA356
CAIX
PreINDP1P2P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved